Dosage Forms and Methods for Diagnosing Sympathetic Nervous System Dysfunction

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

14810842

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Described are methods for detecting and/or diagnosing systemic sympathetic nervous system dysfunction or disease in a subject. One embodiment comprises using a topical apraclonidine eye drop to detect an ocular condition indicative of sympathetic dysfunction or disease in a subject with Guillain-Barré syndrome (GBS). Embodiments can be used to detect and/or diagnose systemic sympathetic nervous system dysfunction or disease early, prior to development of substantial symptoms. Embodiments can also be used to unmask either bilateral ptosis or bilateral Horner's syndrome in GBS patients with the application of the drop to one eye. Also described are dosage forms suitable for use in the methods described herein. The dosage forms comprise an alpha receptor agonist with alpha-1 receptor activity. In one embodiment the dosage form comprises apraclonidine packaged as a single-use eye drop.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
KINGSTON HEALTH SCIENCES CENTRE76 STUART STREET KINGSTON ON K7L 2V7

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Panosyan, Francis B Kingston, CA 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation